145 related articles for article (PubMed ID: 36509740)
1. Consensus opinion from an international group of experts on measurable residual disease in hairy cell leukemia.
Ravandi F; Kreitman RJ; Tiacci E; Andritsos L; Banerji V; Barrientos JC; Bhat SA; Blachly JS; Broccoli A; Call T; Chihara D; Dearden C; Demeter J; Dietrich S; Else M; Epperla N; Falini B; Forconi F; Gladstone DE; Gozzetti A; Iyengar S; Johnston JB; Jorgensen J; Juliusson G; Lauria F; Lozanski G; Parikh SA; Park JH; Polliack A; Quest G; Robak T; Rogers KA; Saven A; Seymour JF; Tadmor T; Tallman MS; Tam CS; Thompson PA; Troussard X; Zent CS; Zenz T; Zinzani PL; Wörmann B; Rai K; Grever M
Blood Cancer J; 2022 Dec; 12(12):165. PubMed ID: 36509740
[TBL] [Abstract][Full Text] [Related]
2. Cladribine in hairy cell leukemia.
Belani R; Saven A
Hematol Oncol Clin North Am; 2006 Oct; 20(5):1109-23. PubMed ID: 16990111
[TBL] [Abstract][Full Text] [Related]
3. Minimal residual disease, its detection and significance in hairy-cell leukemia.
Zák P; Chrobák L; Dĕdic K
Acta Medica (Hradec Kralove); 1999; 42(3):85-8. PubMed ID: 10677893
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood 8 colour flow cytometry monitoring of hairy cell leukaemia allows detection of high-risk patients.
Garnache Ottou F; Chandesris MO; Lhermitte L; Callens C; Beldjord K; Garrido M; Bedin AS; Brouzes C; Villemant S; Rubio MT; Belanger C; Suarez F; Deau B; Lefrère F; Hermine O; Asnafi V; Varet B; Macintyre E
Br J Haematol; 2014 Jul; 166(1):50-9. PubMed ID: 24661013
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of hairy cell leukemia as the COVID-19 pandemic continues.
Kreitman RJ; Arons E
Blood Rev; 2022 Jan; 51():100888. PubMed ID: 34535326
[TBL] [Abstract][Full Text] [Related]
6. [Hairy cell leukemia. An alternative method for the detection of minimal residual disease using flow cytometry].
Bengio R; Narbaitz M; Palacios F; Scolnik M; Sarmiento M
Medicina (B Aires); 2000; 60 Suppl 2():71-6. PubMed ID: 11188936
[TBL] [Abstract][Full Text] [Related]
7. Definition of remission, minimal residual disease, and relapse in hairy cell leukemia bone marrow biopsy histology and immunohistology specimens.
Noel P
Leuk Lymphoma; 2011 Jun; 52 Suppl 2():62-4. PubMed ID: 21463123
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
9. Minimal residual disease detection in hairy cell leukemia. Comparison of flow cytometric immunophenotyping with clonal analysis using consensus primer polymerase chain reaction for the heavy chain gene.
Sausville JE; Salloum RG; Sorbara L; Kingma DW; Raffeld M; Kreitman RJ; Imus PD; Venzon D; Stetler-Stevenson M
Am J Clin Pathol; 2003 Feb; 119(2):213-7. PubMed ID: 12579991
[TBL] [Abstract][Full Text] [Related]
10. Measurable residual disease in hairy cell leukemia: Technical considerations and clinical significance.
Robak T; Robak P
Front Oncol; 2022; 12():976374. PubMed ID: 36439497
[TBL] [Abstract][Full Text] [Related]
11. Minimal residual disease in hairy cell leukemia patients assessed by clone-specific polymerase chain reaction.
Arons E; Margulies I; Sorbara L; Raffeld M; Stetler-Stevenson M; Pastan I; Kreitman RJ
Clin Cancer Res; 2006 May; 12(9):2804-11. PubMed ID: 16675574
[TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease may predict bone marrow relapse in patients with hairy cell leukemia treated with 2-chlorodeoxyadenosine.
Wheaton S; Tallman MS; Hakimian D; Peterson L
Blood; 1996 Feb; 87(4):1556-60. PubMed ID: 8608247
[TBL] [Abstract][Full Text] [Related]
13. Biology and Treatment of Hairy Cell Leukemia.
Paillassa J; Troussard X
Curr Treat Options Oncol; 2020 Apr; 21(6):44. PubMed ID: 32350628
[TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse.
Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC
Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066
[TBL] [Abstract][Full Text] [Related]
15. Hairy cell leukemia: present and future directions.
Kreitman RJ
Leuk Lymphoma; 2019 Dec; 60(12):2869-2879. PubMed ID: 31068044
[TBL] [Abstract][Full Text] [Related]
16. A single course of 2-chloro-deoxyadenosine does not eradicate leukemic cells in hairy cell leukemia patients in complete remission.
Filleul B; Delannoy A; Ferrant A; Zenebergh A; Van Daele S; Bosly A; Doyen C; Mineur P; Glorieux P; Driesschaert P
Leukemia; 1994 Jul; 8(7):1153-6. PubMed ID: 7913513
[TBL] [Abstract][Full Text] [Related]
17. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
18. Hairy cell leukemia.
Ravandi F
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S254-9. PubMed ID: 19778849
[TBL] [Abstract][Full Text] [Related]
19. Significance of recurrence of minimal residual disease detected by multi-parameter flow cytometry in patients with acute lymphoblastic leukemia in morphological remission.
Pemmaraju N; Kantarjian H; Jorgensen JL; Jabbour E; Jain N; Thomas D; O'Brien S; Wang X; Huang X; Wang SA; Konopleva M; Konoplev S; Kadia T; Garris R; Pierce S; Garcia-Manero G; Cortes J; Ravandi F
Am J Hematol; 2017 Mar; 92(3):279-285. PubMed ID: 28052371
[TBL] [Abstract][Full Text] [Related]
20. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
